UNITED STATES SECURITIES AND EXCHANGE COMMISSION
                            WASHINGTON, DC  20549

                                FORM 10-QSB


(Mark One)
[X] QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT
OF 1934 FOR THE QUARTERLY PERIOD ENDED July 26, 2008.

[ ] TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE EXCHANGE ACT FOR THE
TRANSITION PERIOD FROM ______________ TO _____________.


                       COMMISSION FILE NUMBER: 0-1455


                          OPT-SCIENCES CORPORATION
       (Exact name of small business issuer as specified in its charter)

                NEW JERSEY                             21-0681502
      (State or other jurisdiction of                 (I.R.S. Employer
       incorporation or organization)                Identification No.)

             1912 BANNARD STREET, CINNAMINSON, NEW JERSEY 08077
                  (Address of principal executive offices)


                              (856) 829-2800
                         Issuer's telephone number

                              Not applicable
(Former name, former address and former fiscal year, if changed since last
Report)

Check whether the issuer (1) filed all reports required to be filed by Section
13 or 15(d) of the Exchange Act during the past 12 months (or for such shorter
period that the registrant was required to file such reports), and (2) has
been subject to such filing requirements for the past 90 days.
YES [X]  NO [ ]

Indicate by check mark whether the registrant is a shell company(as defined
in Rule 12b-2 of the Exchange Act).                            YES [ ]  NO [X]

State the number of shares outstanding of each of the issuer's classes of
common equity, as of the latest practical date: 775,585 Shares of Common Stock,
par value $.025, were outstanding as of August 31, 2008

Transitional Small Business Format (Check one)                YES [ ]  NO [X]







                             TABLE OF CONTENTS

             FORM 10-QSB THIRD QUARTER REPORT - FISCAL YEAR 2008
                  OPT-SCIENCES CORPORATION AND SUBSIDIARY
                                                                         PAGE

PART I    FINANCIAL INFORMATION

Item 1.   Financial Statements............................................  3

          Consolidated Balance Sheets -
             July 26, 2008(unaudited) and October 27, 2007................  3

          Consolidated Statements of Income and Retained Earnings (unaudited)
             fourteen and forty weeks ended July 26, 2008 and
             thirteen and thirty-nine weeks ended July 28, 2007  .........  5

          Consolidated Statements of Cash Flows (unaudited)-
             forty weeks ended July 26, 2008 and
             thirty-nine weeks ended July 28, 2007........................  6

          Notes to Consolidated Financial Statements......................  7

Item 2.   Management's Discussion and Analysis and Result of Operations.....8
             Cautionary Statement Regarding Forward-Looking Information
             Critical Accounting Policies and Estimates
             Executive Summary
             Results of Operations
             Financial Condition
             Risks and Uncertainties

Item 3.   Controls and Procedures..........................................12

PART II   OTHER INFORMATION

Item 1.   Legal Proceedings................................................13

Item 2.   Unregistered Sales of Equity Securities and Use of Proceeds......13

Item 3.   Defaults Upon Senior Securities..................................13

Item 4.   Submission of Matters to a Vote of Security Holders..............13

Item 5.   Other Information................................................13

Item 6.   Exhibits.........................................................13

Signatures ................................................................13








			PART I    FINANCIAL INFORMATION

ITEM 1.    FINANCIAL STATEMENTS

                             Opt-Sciences Corporation
                            CONSOLIDATED BALANCE SHEETS

                                     ASSETS

                                        July 26, 2008   October 27, 2007
                                         (unaudited)
CURRENT ASSETS

   Cash and cash equivalents             $ 6,411,276        $6,777,104
   Trade accounts receivable               1,345,012         1,012,659
   Inventories                               541,297           592,660
   Prepaid expenses                            7,782            21,074
   Loans and exchanges                         4,140             4,390
   Deferred income taxes                      47,183                -0-
   Marketable securities                     885,941           890,161
     Total current assets                  9,242,631         9,298,048


PROPERTY AND EQUIPMENT

   Land                                      114,006           114,006
   Building and improvements                 513,447           449,987
   Machinery and equipment                 1,528,558         1,485,573
   Small tools                                53,580            53,580
   Furniture and fixtures                     14,683             8,624
   Office equipment                           57,419            57,419
   Automobiles                                71,211            71,211

    Total property and
           equipment                       2,352,904         2,240,400

  Less:  accumulated depreciation          1,736,892         1,652,891

    Net property and equipment               616,012           587,509


OTHER ASSETS

   Deposits                                  235,487             2,837

     Total assets                        $10,094,130        $9,888,394










                          Opt-Sciences Corporation
                          CONSOLIDATED BALANCE SHEETS

                     LIABILITIES AND STOCKHOLDERS' EQUITY



                                              July 26, 2008  October 27, 2007
                                               (unaudited)

CURRENT LIABILITIES

   Accounts payable - trade                    $    80,200       $   86,759
   Accrued income taxes                             65,062          267,980
   Accrued salaries and wages                      187,925          272,328
   Accrued professional fees                        61,750           63,925
   Deferred income taxes                               -0-           30,100
   Other current liabilities                        17,376            2,570

        Total current liabilities                  412,313          723,662


STOCKHOLDERS' EQUITY

   Common capital stock - par value
     $.025 per share - authorized
     and issued 1,000,000 shares                   250,000         250,000
   Additional paid in capital                      272,695         272,695
   Retained earnings                             9,429,905       8,810,376
   Accumulated other comprehensive (loss)income    (83,565)         18,879
   Less treasury stock at cost -
     224,415 shares and 224,415 shares            (187,218)       (187,218)


   Total stockholders' equity                    9,681,817       9,164,732

             Total liabilities and
                stockholders' equity           $10,094,130      $9,888,394





















     CONSOLIDATED STATEMENTS OF INCOME AND RETAINED EARNINGS (unaudited)

                      Fourteen      Thirteen         Forty       Thirty-Nine
                       Weeks         Weeks           Weeks         Weeks
                       Ended         Ended           Ended         Ended
                      July 26,      July 28,        July 26,      July 28,
                        2008          2007            2008          2007

NET SALES            $1,848,706    $1,608,602      $4,853,089    $4,074,846

COST OF SALES         1,177,825       997,649       3,205,788     2,694,864

  Gross profit
     on sales           670,881       610,953       1,647,301     1,379,982

OPERATING EXPENSES
  Sales & delivery       13,619         9,283          36,528        30,457
  General and
     administrative     210,439       228,289         690,695       628,742

  Total operating
     expenses           224,058       237,572         727,223       659,199

  Operating income      446,823       373,381         920,078       720,783

OTHER INCOME             47,950        71,897         166,751       228,640

   Net income
      before taxes      494,773       445,278       1,086,829       949,423

FEDERAL AND STATE
  INCOME TAXES          212,700       191,500         467,300       408,200

  Net income            282,073       253,778         619,529       541,223

RETAINED EARNINGS -
   beginning of
     period           9,147,832     8,265,060       8,810,376     7,977,615

RETAINED EARNINGS -
   end of
     period          $9,429,905    $8,518,838      $9,429,905    $8,518,838

EARNINGS PER SHARE OF
   COMMON STOCK            0.36          0.33            0.80          0.70

Average shares of stock
  outstanding           775,585       775,585         775,585       775,585









                 CONSOLIDATED STATEMENTS OF CASH FLOWS (unaudited)

                                                Forty           Thirty Nine
                                             Weeks Ended        Weeks Ended
                                            July 26, 2008      July 28, 2007

CASH FLOWS FROM OPERATING ACTIVITIES
Net income                                   $  619,529        $  541,223

Adjustments to reconcile net income to net
cash provided by operating activities:
   Depreciation                                  84,001            86,904
   Loss (gain) on sale of securities             20,031           (27,049)

   Decrease (increase) in:
     Accounts receivable                       (332,353)         (359,567)
     Inventories                                 51,363            21,811
     Prepaid expenses                            13,292            25,524
     Prepaid income taxes                            -0-           23,900
     Loans and exchanges                            250               137

  (Decrease) increase in:
     Accounts payable                            (6,559)           19,659
     Accrued income taxes                      (202,918)          206,582
     Accrued salaries and wages                 (84,403)            5,417
     Accrued professional fees                   (2,175)          (12,225)
     Other current liabilities                   14,806             6,939

       Net cash provided by
       operating activities                     174,864           539,255

CASH FLOWS FROM INVESTING ACTIVITIES
   Additions to property and equipment         (112,504)          (47,135)
   Deposits                                    (232,650)               -0-
   Purchases of securities                     (480,503)         (391,289)
   Proceeds from sales of securities            284,965           295,725

      Net cash (used) by
       investing activities                    (540,692)         (142,699)

(Decrease) increase in cash                    (365,828)          396,556

Cash and cash equivalents
   at beginning of period                     6,777,104         5,798,506

Cash and cash equivalents
   at end of period                          $6,411,276        $6,195,062

SUPPLEMENTAL DISCLOSURES:
   Income taxes paid                         $  670,218        $  177,718









NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

1. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

The accompanying consolidated financial statements include the accounts of
Opt-Sciences Corporation, Inc. and its wholly-owned subsidiary, O&S Research,
Inc. All significant intercompany accounts and transactions have been
eliminated in consolidation.

These consolidated financial statements have been prepared by the Company,
without audit, and reflect normal recurring adjustments which, in the opinion
of management, are necessary for a fair statement of the results for the
first nine months of the Company's fiscal year 2008.  These consolidated
financial statements do not include all disclosures associated with annual
consolidated financial statements and, accordingly, should be read in
conjunction with footnotes contained in the Company's consolidated financial
statements for the year ended October 27, 2007 together with the auditors'
report filed as part of the Company's 2007 Annual Report on Form 10-KSB.

The preparation of these consolidated financial statements requires the
Company to make estimates and judgments that affect the reported amounts of
assets, liabilities, revenues and expenses. The Company bases its estimates
on historical experience and on various other assumptions that are believed
to be reasonable under the circumstances, the results of which form the basis
for making judgments about the carrying values of assets and liabilities that
are not readily apparent from other sources. Actual results may differ from
these estimates under different assumptions or conditions.

2. INVENTORIES

Inventories consisted of the following:

                                   July 26, 2008           October 27, 2007
                                    (Unaudited)

  Raw materials and supplies      $234,170               $215,935
  Work in progress                 266,367                332,089
  Finished goods                    40,760                 44,636

     Total Inventory              $541,297               $592,660

End of quarter inventories are stated at the lower of cost (first-in, first-
out) or market and are based on estimates rather than a physical inventory. A
physical inventory is conducted at the end of the fiscal year. The Company
provides for estimated obsolescence on unmarketable inventory based upon
assumptions about future demand and market conditions. If actual demand and
market conditions are less favorable than those projected by management,
additional inventory write downs may be required. Inventory, once written
down, is not subsequently written back up, as these adjustments are
considered permanent adjustments to the carrying value of the inventory.
Historically, the Company conducts a physical inventory annually in
connection with its audited financial statements and preparation of its
Form 10-KSB. The inventory appearing on unaudited quarterly financial
statements and in Form 10-QSB is based on estimates derived from an
unaudited physical inventory count of work-in-progress and raw materials.

3. REVENUE RECOGNITION

The Company recognizes revenue in accordance with U.S. GAAP and SEC Staff
Accounting Bulletin ("SAB") No. 104, Revenue Recognition. SAB No. 104
requires that four basic criteria must be met before revenue can be
recognized: (1) persuasive evidence of an arrangement exists; (2) delivery
has occurred or services have been rendered; (3) the price to the buyer is
fixed and determinable; and (4) collectibility is reasonably assured.
Determination of criteria (3) and (4) are based on management's judgments
regarding the fixed nature of the price to the buyer charged for products
delivered or services rendered and collectibility of the sales price. The
Company assesses credit worthiness of customers based upon prior history
with the customer and assessment of financial condition. The Company's
shipping terms are customarily FOB shipping point.

4. RECENTLY ISSUED ACCOUNTING PRONOUNCEMENTS

In June 2006, the Financial Standards Accounting Board (FASB) issued
interpretation No. 48, Accounting for Uncertainty in Income Taxes, an
interpretation of FASB statement No. 109. Interpretation 48 clarifies the
accounting for uncertainty in income taxes recognized in an entity's
financial statements in accordance with Statement 109 and prescribes a
recognition threshold and measurement attribute for financial statement
recognition and measurement of a tax position taken or expected to be
taken in a tax return.  Additionally, Interpretation 48 provides guidance
on derecognition, classification, interest and penalties, accounting in
interim periods, disclosure and transition.  Interpretation 48 is
effective for fiscal years beginning after December 15, 2006 with early
adoption permitted.  We have adopted Interpretation 48 for our fiscal year
2008, and do not currently expect the adoption of Interpretation 48 to
have an impact on our financial statements.

5. DEPOSITS

The company has made a deposit of $235,487 for the new thin film coating
equipment ordered in the last quarter.

ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS AND RESULTS OF OPERATIONS

CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING INFORMATION

We make statements in this Report, and we may from time to time make other
statements, regarding our outlook or expectations for earnings, revenues,
expenses and/or other matters regarding or affecting the Company that are
forward-looking statements within the meaning of the Private Securities
Litigation Reform Act. Forward-looking statements are typically identified by
words such as "believe," "expect," "anticipate," "intend," "outlook,"
"estimate," "forecast," "project" and other similar words and expressions.
Forward-looking statements are subject to numerous assumptions, risks and
uncertainties, which change over time. Forward-looking statements speak only
as of the date they are made. We do not assume any duty and do not undertake
to update our forward-looking statements. Actual results or future events
could differ, possibly materially, from those that we anticipated in our
forward-looking statements, and future results could differ materially from
our historical performance. Our forward-looking statements are subject to the
following principal risks and uncertainties.

   -Uncertainties about the future demand for the Company's products;
   -Risks associated with dependence on a few major customers;
   -The timing and completion of significant orders; and
   -The performance and reliability of the Company's vendors.

We provide greater detail regarding these factors in our 2007 Form 10-KSB,
including in the Company Risk Factors section. Our forward-looking
statements may also be subject to other risks and uncertainties including
those discussed in the Risks and Uncertainties section of this Quarterly
Report or in our other filings with the SEC.

CRITICAL ACCOUNTING POLICIES AND ESTIMATES
Management's discussion and analysis of financial condition and results of
operations are based upon the Company's consolidated financial statements,
which have been prepared in accordance with accounting principles generally
accepted in the United States of America ("U.S. GAAP"). The preparation of
these financial statements requires the Company to make estimates and
judgments that affect the reported amounts of assets, liabilities, revenues
and expenses. The Company bases its estimates on historical experience and on
various other assumptions that are believed to be reasonable under the
circumstances, the results of which form the basis for making judgments about
the carrying values of assets and liabilities that are not readily apparent
from other sources. Actual results may differ from these estimates under
different assumptions or conditions. Specifically, inventory is estimated
quarterly and reconciled at the end of the fiscal year when a comprehensive
physical count is conducted (also see Notes to Consolidated Financial
Statements, Note 1 Summary of Significant Accounting Policies and Note 2
Inventories).

EXECUTIVE SUMMARY
Opt-Sciences Corporation, through its wholly owned subsidiary, O & S Research,
Inc., both New Jersey corporations, manufactures anti-glare and transparent
conductive optical coatings which are deposited on glass used primarily to
cover instrument panels in aircraft cockpits. The Company's business is highly
dependent on a robust commercial, business, regional and military aircraft
market. We recorded third quarter sales of $1,848,706 and net income of
$282,073. Sales are up 14.9% and net income is up 11.1% from the third quarter
of 2007. We currently expect fourth quarter sales to be approximately
$1,800,000. In addition, we project revenues this fiscal year at over
$6,600,000. All of our markets are currently good and we project they will
gradually become better. Nevertheless, we recognize that a possible economic
recession driven by high energy costs could affect the ability of our ultimate
commercial customers to purchase or upgrade aircraft, thus reducing the demand
for the Company's products. During the third quarter of 2008, the Company
booked $1,640,000 in new orders compared to $1,214,000 in new orders booked
for the third quarter of 2007. Our backlog of unshipped orders was
approximately $2,233,700 at the end of third quarter, up $266,800 from
$1,966,900 at the end of the third quarter of 2007. We believe that our
backlog level will fluctuate between $1.8 and $2.2 million for the
foreseeable future. Of course, this could change significantly based on how
long the Boeing machinist strike lasts. During the strike, Boeing will not
be making any new airplanes. We generally have a four to twelve week delivery
cycle depending on product complexity, available plant capacity and required
lead time for specialty raw materials such as polarizers or filter glass. Our
sales tend to fluctuate from quarter to quarter because all orders are custom
manufactured and customer orders are generally scheduled for delivery based
on our customer's need date and not based on our ability to make shipments.
Since the Company has two customers that together represent over 50% of sales,
any significant change in the requirements of either of those customers has a
direct impact on our revenue for the quarter. When one of these customers
defers a sizable order, sales for the following quarter often rebound as the
customer replenishes its inventory.


RESULTS OF OPERATIONS

FOURTEEN WEEKS ENDED JULY 26, 2008 COMPARED WITH THIRTEEN WEEKS ENDED
JULY 28, 2007

Net Sales.
Net sales for the third quarter ended July 26, 2008 were $1,848,706 which is
$240,104 and 14.9% more than the net sales of $1,608,602 for the same quarter
last year. This increase is the result of higher demand for the Company's
cover glass products.

Cost of Sales.
Cost of sales for the quarter ended July 26, 2008 increased $180,176 or 18.1%
to 1,177,825 or 63.7% of sales, compared to 997,649 or 62.0% of sales, for the
same quarter last year. Cost of sales is comprised of raw materials,
manufacturing direct labor and overhead expenses.  The overhead portion of cost
of sales is primarily comprised of salaries, benefits, building expenses,
production supplies, and maintenance costs related to our production, inventory
control and quality departments.

Gross Profit.
Gross profit for the quarter ended July 26, 2008 increased $59,928 to $670,881
or 36.3% of sales from $610,953 or 38.0% of sales reported for the same quarter
last year.

Operating Expenses.
Operating expenses decreased $13,514 or 5.7% to $224,058 from $237,572 for the
same quarter last year. Operating expenses consist of marketing and business
development expenses, professional expenses, salaries and benefits for executive
and administrative personnel, hiring, legal, accounting, and other general
corporate expenses.

Operating Income.
The Company realized operating income of $446,823 or 24.2% of sales, for the
quarter ended July 26, 2008, compared to operating income of $373,381 or 23.2%
of sales, for the same quarter last year.

Other Income.
Other income of $47,950 for the third quarter of fiscal year 2008 decreased
$23,947 from that for the same quarter last year, primarily due to lower
interest rates and reduced yields on investments.

Income Tax.
Income tax expense for the third quarter ended July 26, 2008 was $212,700 or
43% of pre-tax income, compared to 191,500 and 43% of pre-tax income for the
third quarter ended July 28, 2007.

Net Income.
Net income for the third quarter ended July 26, 2008 was $282,073 or $0.36 per
share, compared to net income of $253,778 or $0.33 per share, for the third
quarter ended July 28, 2007.


FORTY WEEKS ENDED July 26, 2008 COMPARED WITH THIRTY-NINE WEEKS ENDED
JULY 28, 2007

Net Sales.
Net sales for the nine months ended July 26, 2008 were $4,853,089 which is
$778,243 and 19.1% more than the net sales of $4,074,846 for the same period
last year. This is primarily due to increased customer demand for the
company's products.

Cost of Sales.
Cost of sales for the nine months ended July 26, 2008 was $3,205,788 or 66.1%
of sales, compared to $2,694,864 or 66.1% of sales, for the same period last
year.  The increase in cost of sales by $510,924 corresponds to the increase
in revenues between the same nine month periods as noted above.

Gross Profit.
Gross profit for the nine months ended July 26, 2008 increased $267,319 to
$1,647,301 or 33.9% of sales, from $1,379,982 or 33.9% of sales, reported
for the same period last year.

Operating Expenses.
Operating expenses increased by $68,024 or 10.3% to $727,223 during the nine
month period ended July 26, 2008 from $659,199 during the nine month period
ended July 28, 2007 primarily due to increased payroll related expenses,
medical insurance and professional fees.

Operating Income.
The Company realized operating income of $920,078 or 19.0% of sales, for the
nine month period ended July 26, 2008, compared to operating income of
$720,783 or 17.7% of sales, for the same period last year.  The increase is
the result of increased sales and increased gross margin noted above.

Other Income.
Other income of $166,751 for the nine month period ended July 26, 2008
decreased $61,889 from that for the same period for last year, primarily
due to lower interest rates and reduced yields on investments.

Income Tax.
Income tax expense for the nine month period ended July 26, 2008 was
$467,300 or 43.0% of net income before taxes, compared to $408,200 and 43.0%
for the nine month period ended July 28, 2007.

Net Income.
Net income for the nine month period ended July 26, 2008 increased $78,306 or
14.5% to $619,529 or $0.80 per share, compared to net income of $541,223 or
$0.70 per share for the prior comparable period.

FINANCIAL CONDITIONS
The Company utilizes its working capital to finance current operations and
capital improvements. Cash and cash equivalents have decreased from $6,777,104
at the end of the fiscal year on October 27, 2007 to $6,411,276 at the end
of the following nine month period ended July 26, 2008. The Company has
ordered approximately $550,000 of new capital equipment to provide additional
capacity for anti-reflective and conductive coatings. Total costs are
expected to be approximately $650,000 including installation. The coating
unit is now expected to be operational in mid-October, 2008. Depending on
market conditions at that time, the Company may order another coating machine.
The fluctuations in cash and cash equivalents are primarily a result of net
income, payment of a deposit on the new equipment, payment of income taxes
and investments in the Company's portfolio of securities.  The Company
maintains a strong liquidity position in order to improve its ability to
deal with the risks and uncertainties identified below.

RISKS AND UNCERTAINTIES

The Company faces numerous challenges in its markets.  In our view, the
following are among the most important:

  - The Company's historic aircraft instrument glass wedges are being
    purchased less frequently than LCD displays and are becoming
    technologically obsolete.

  - LCD displays now commonly used for new aircraft instruments are larger
    in size than the smaller, specialized lenses they replace. The LCD
    display design requires a simpler less expensive cover glass that the
    Company manufactures. Businesses not active in the glass wedge market can
    more easily manufacture the cover glasses for LCDs in competition with
    the Company.

  - The Company has become more active in the market for providing cover
    glass with both conductive coating and anti reflective coating.  In
    anticipation of increased demand for such products, the Company has
    purchased a new vacuum chamber and is considering an additional purchase.
    If the Company expectations for demand are incorrect, the Company will
    have devoted significant resources to installing unnecessary
    manufacturing capacity.

  - We face increasing competition from established companies that have
    significantly greater resources. Certain of our competitors enjoy
    substantial competitive advantages, such as:

     (a) Greater corporate name recognition, larger marketing budgets and
     greater resources,
     (b) Established marketing relationships and access to larger customer
     bases, and
     (c) Substantially greater financial, technical and other resources.

  - Section 404 of the Sarbanes-Oxley Act of 2002 will require the Company to
    perform an assessment of its financial reporting controls, and to report
    on that assessment in the Company's Annual Report on Form 10K for the
    Fiscal Year 2008.  Section 404 will require that our public accounting
    firm audit our internal controls in a subsequent fiscal year. The Company
    expects its operating expenses will increase further as a result of the
    costs associated with implementation of and maintaining compliance with
    Section 404 and other provisions of the Sarbanes-Oxley Act.



ITEM 3. CONTROLS AND PROCEDURES

a.  Evaluation Of Disclosure Controls And Procedures.  Based on his evaluation
as of the end of the periods covered by this report, the Company's chief
executive officer and chief financial officer concluded that the Company's
disclosure controls and procedures referred to in paragraph 4(c) of his
Certification included as an exhibit to this report were effective.


b.  Changes In Internal Controls.  During the period covered by this report,
the Company has not made any change to its internal controls over financial
reporting as referred to in paragraph 4(d) of the Certification of the
Company's principal executive officer and principal financial officer included
as an exhibit to this report that has materially affected, or is reasonably
likely to materially affect the Company's internal control over financial
reporting.


                         PART II - OTHER INFORMATION

ITEM 1.  LEGAL PROCEEDINGS

We are subject to certain claims and litigation in the ordinary course of
business. It is the opinion of management that the outcome of such matters
will not have a material adverse effect on our combined financial position
or results of operations.

ITEM 2.  UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

         None

ITEM 3.  DEFAULTS UPON SENIOR SECURITIES

         Not applicable

ITEM 4.  SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS

         Not applicable

ITEM 5.  OTHER INFORMATION

         None.

ITEM 6.  EXHIBITS

(a) EXHIBITS
    31.1 Certification of Chief Executive Officer and Chief Financial Officer
pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

    32.1 Certification of Chief Executive Office and Chief Financial Officer
pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

Signatures

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange
Act of 1934, the Registrant has duly caused this Report to be signed on its
behalf by the undersigned thereunder duly authorized.

                                                  OPT-SCIENCES CORORATION

                                                  By: /s/Anderson L. McCabe
                                                  ------------------------
                                                  Anderson L. McCabe
                                                  Chief Executive Officer
                                                  and Chief Financial Officer
                                                  Dated: September 9, 2008
EXHIBIT 31.1

Certification of Chief Executive Officer and Chief Financial
Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

I, Anderson L. McCabe, as CEO and CFO of Opt-Sciences Corporation, certify
that:

1. I have reviewed this quarterly report of Opt-Sciences Corporation;

2. Based on my knowledge, this report does not contain any untrue statement
of a material fact or omit to state a material fact necessary to make the
statements made, in light of the circumstances under which such statements
were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial
information included in this report, fairly present in all material respects
the financial condition, results of operations and cash flows of Opt-Sciences
Corporation as of, and for, the periods presented in this report;

4. I am responsible for establishing and maintaining disclosure controls and
procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and
internal control over financial reporting (as defined in Exchange Act Rules
13a-15(f) and 15d-15(f)) for Opt-Sciences Corporation and have:

(a) Designed such disclosure controls and procedures, or caused such
disclosure controls and procedures to be designed under my supervision, to
ensure that material information relating to Opt-Sciences Corporation,
including its consolidated subsidiaries, is made known to me by others within
those entities, particularly during the period in which this report is being
prepared;

(b) Designed such internal control over financial reporting, or caused such
internal control over financial reporting to be designed under my supervision,
to provide reasonable assurance regarding the reliability of financial
reporting and the preparation of financial statements for external purposes
in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of Opt-Sciences Corporation's disclosure
controls and procedures and presented in this report my conclusions about the
effectiveness of the disclosure controls and procedures, as of the end of the
period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in Opt-Sciences Corporation's internal
control over financial reporting that occurred during Opt-Sciences
Corporation's most recent fiscal quarter that has materially affected, or is
reasonably likely to materially affect, Opt-Sciences Corporation's internal
control over financial reporting; and

5. I have disclosed, based on my most recent evaluation of internal control
over financial reporting, to Opt-Sciences Corporation's auditors and the audit
committee of Opt-Sciences Corporation's board of directors (or persons
performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or
operation of internal control over financial reporting which are reasonably
likely to adversely affect Opt-Sciences Corporation's ability to record,
process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other
employees who have a significant role in Opt-Sciences Corporation's internal
control over financial reporting.

                                       /s/Anderson L. McCabe
                                       ---------------------
                                       Name: Anderson L. McCabe
                                       Title: Chief Executive Officer/
                                              Chief Financial Officer
                                       Dated: September 9, 2008

EXHIBIT 32.1

Certification of Chief Executive Officer and Chief Financial Officer pursuant
to Section 906 of the Sarbanes-Oxley Act of 2002.

I, Anderson L. McCabe as CEO and CFO of Opt-Sciences Corporation (the
"Company"), certify to my knowledge, pursuant to section 906 of the Sabanes-
Oxley Act of 2002, 18 U.S.C. Section 1350, that:

(1) the Quarterly Report on Form 10-QSB of the Company for the quarterly
period ended July 26, 2008 (the "Report") fully complies with the requirements
of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C.
78m or 78o(d)); and

(2)the information contained in the Report fairly presents, in all material
respects, the financial condition and results of operations of the Company.

                                       /s/Anderson L. McCabe
                                       ---------------------
                                       Name: Anderson L. McCabe
                                       Title: Chief Executive Officer/
                                              Chief Financial Officer
                                       Dated: September 9, 2008








- 15 -